Thermo Fisher Scientific Sponsors Industry Symposia on Stem Cell Research
News Jun 10, 2008
Thermo Fisher Scientific Inc. has announced its sponsorship of the Industry Wednesday Symposia in Philadelphia on June 11, preceding the 6th International Society for Stem Cell Research (ISSCR) Annual Meeting.
With presentations from leading experts, the Thermo Fisher Scientific symposium, “Strategies and Current Technologies for Accelerating Stem Cell Research”, will provide stem cell scientists with information on the latest tools and techniques available for their research.
The symposium showcases the expertise of Thermo Fisher Scientific around key stem cell research technologies as presented through the company’s Stem Cell Excellence™ program, which was introduced in 2007.
Speakers from industrial and clinical backgrounds will cover topics ranging from the practical considerations for the differentiation of mesenchymal stem cells into hepatocyte-like cells, and the current and future use of pluripotent stem cells.
Thermo Fisher Scientific says that, the delegates will learn about new methods for the quantitative detection of up-regulated and down-regulated proteins and explore techniques used for the discovery and characterization of regulatory molecules involved with differentiation.
Dr. Yair Argon from the department of pathology, Children’s Hospital of Philadelphia, will present data and discuss how the identified GRP94-dependent proteins are essential for embryonic development and the differentiation of embryonic stem cells.
Further topics include: the differentiation of adipose derived and Wharton’s jelly derived mesenchymal stem cells into hepatocyte-like cells, presented by Anant Kamath, COO of Cellular Engineering Technologies; and the current and future uses of pluripotent stem cells, delivered by Robin Wesselschmidt, President of Primogenix.
Thermo Fisher Scientific will also be providing in-depth presentations on the use of RNAi screening for the identification of critical miRNAs for human mesenchymal stem cell differentiation, and the use of high content analysis to accelerate stem cell research.
Julie Sperry, vice president, strategic marketing, Thermo Fisher Scientific said, “We are dedicated to serving the scientific community and feel our wealth of in-house expertise and breadth of best-in-class products can support stem cell scientists with their pioneering research.” Sperry continued, “As such we are delighted to be aligned with this society event. With an excellent program of presentations, we aim to provide information on the technologies and strategies that are currently being applied.”
Schizophrenics' Blood Contains RNA From More MicrobesNews
The blood of schizophrenia patients features genetic material from more types of microorganisms than that of people without the debilitating mental illness, research at Oregon State University has found. What’s not known is whether that’s a cause or effect of the severe, chronic condition that strikes about one person in 100.READ MORE
How Hematopoietic Stem Cells Balance Activation and DormancyNews
Researchers have shown how intracellular signalling can safeguard the delicate balance between hematopoietic stem cell activation and dormancy.READ MORE
Faulty Gene Leads to Alcohol-Induced Heart FailureNews
A faulty gene interacts with alcohol to accelerate heart failure in susceptible patients, a study suggests. This dangerous interaction can occur even when only moderate amounts of alcohol have been consumed.READ MORE